|
|
3Christie Ballantyne
![]() Summary for 2003 [at-glance overview of Christie Ballantyne work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author Christie Ballantyne. According to available data, in 2003 Christie Ballantyne published at least 3 articles. This work was completed in collaboration with several authors including Serruys, Patrick W and Ridker, Paul M. Many other authors have collaborated with Christie Ballantyne as well. At least 3 different grants are awarded to Christie Ballantyne to support this work. All time total of the grant awards on file exceeds $3,250,391.
Analysis of the article abstracts and the titles suggests that Christie Ballantyne professional interests are focused around "acute coronary syndromes", "sudden cardiac death" and "coronary heart disease". These might also be referred to as "vulnerable patients", "vulnerable plaque" or "risk assessment". Statistical analysis shows that Christie Ballantyne's writing is likely to contains terms "vulnerable", "patients", "plaque", "coronary", "plaques" and "psgl-1".
The majority of Christie Ballantyne articles are affiliated with The Center for Vulnerable Plaque Research, University of Texas-Houston, The Texas Heart Institute, and President Bush Center for Cardiovascular Health, Memorial Hermann Hospital, Houston, USA. Luckily, one email address is on file. Images [images we found on the Internet for Christie Ballantyne]loading...
Do you know Christie Ballantyne who matches the profile above? Click the photo and let us know!
Alternative names (0) [other authors with names similar to Christie Ballantyne]Year 2003 Charts [Christie Ballantyne frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of Christie Ballantyne publication and funding history for the range of years]Emails (1) [email addresses extracted from Christie Ballantyne affiliations]hidden to prevent spam, click here to reveal Christie Ballantyne Coauthors (58) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (2) [condensed summary of the Christie Ballantyne affiliations, the leading number and the color conveys importance]- 2The Center for Vulnerable Plaque Research, University of Texas-Houston, The Texas Heart Institute, and President Bush Center for Cardiovascular Health, Memorial Hermann Hospital, Houston, USA.
1Baylor College of Medicine and the Methodist DeBakey Heart Center, USA.
Key Opinion Leader In [Christie Ballantyne is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]Keywords (32) [keywords assigned to Christie Ballantyne articles by PubMed, the leading number and the color conveys importance]- 3Humans | 2Male | 2Risk Assessment | 2Death, Sudden, Cardiac | 1Leukocytes | 1Severity of Illness Index | 1Animals | 1Monocytes | 1Consensus | 1Platelet Glycoprotein GPIIb-IIIa Complex | 1Time Factors | 1Membrane Glycoproteins | 1Flow Cytometry | 1Inflammation | 1Mass Screening | 1Swine | 1Adult | 1Platelet Activation | 1Middle Aged | 1Macrophage-1 Antigen | 1Platelet Aggregation | 1Disease Susceptibility | 1Female | 1Biological Markers | 1Antibodies, Monoclonal | 1Myocardium | 1Syndrome | 1Terminology | 1Myocardial Infarction | 1Models, Cardiovascular | 1Arteriosclerosis | 1Blood Platelets
Christie Ballantyne Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Christie Ballantyne might be a good expert witness on these terms]- 46vulnerable | 13patients | 12plaque | 12coronary | 12plaques | 11psgl-1 | 8risk | 8assessment | 8part | 8patient | 7disease | 7blood | 6myocardium | 6formation | 6alone | 6ii | 6cardiac | 5pmcs | 5combination | 5will | 5acute | 5syndromes | 5iib | 4victims | 4development | 4heart | 4myocardial | 4sudden | 4future | 4screening | 4field | 4likelihood
- 10vulnerable patients | 10vulnerable plaque | 8risk assessment | 8vulnerable patient | 8vulnerable plaques | 6vulnerable myocardium | 6consensus document | 5acute coronary | 5psgl-1 alone | 5coronary syndromes | 4vulnerable blood | 4heart disease | 4sudden cardiac | 4coronary heart | 4cardiac death | 4part ii | 4assessment strategies | 4patient call | 4plaque vulnerable | 4call definitions | 4strategies part | 4definitions risk | 4assessment vulnerable | 3alone combination | 3platelet-monocyte complex | 3patients vulnerable | 3alpha iib | 3plaques vulnerable | 3iib beta | 3complex formation | 2protein imaging | 2without prior
- 5acute coronary syndromes | 4sudden cardiac death | 4coronary heart disease | 4plaque vulnerable patient | 4patient call definitions | 4vulnerable patient call | 4vulnerable plaque vulnerable | 4call definitions risk | 4definitions risk assessment | 4assessment strategies part | 4risk assessment strategies | 4assessment vulnerable patients | 4risk assessment vulnerable | 3psgl-1 alone combination | 3platelet-monocyte complex formation | 3vulnerable patients vulnerable | 3alpha iib beta | 2developed assays eg | 2relationship vulnerable patients | 2needs developed may | 2definition vulnerable plaque | 2alphaiibbeta3 alphambeta2 coronary | 2treatment coronary heart | 2screening diagnostic methods | 2rapid progression considered | 2consensus document cover | 2mri noninvasive electrophysiological | 2based plaque blood | 2despite major advances | 2variables based plaque | 2recognition role vulnerable | 2part consensus document
Reader's Comments (0) [comments posted by readers of Christie Ballantyne profile]Funding (3) [selected NIH grants to Christie Ballantyne and the award amounts for recent years]- MOLECULAR STUDIES OF ENDOTHELIAL ADHESION MOLECULES (BALLANTYNE, CHRISTIE - 1990)
| Grant # | Award Year | Award Amount, USD | | 5K08HL002537-03 | 1992 | $77,756 | | 5K08HL002537-04 | 1993 | $76,749 | | 5K08HL002537-05 | 1994 | $75,850 | | Total up to 2003 | $230,355 |
- LEUKOCYTE ADHESION MOLECULES AND LEUKOCYTE FUNCTION (BALLANTYNE, CHRISTIE - 1999)
| Grant # | Award Year | Award Amount, USD | | 1R01HL062243-01 | 1999 | $306,480 | | 5R01HL062243-02 | 2000 | $317,570 | | 5R01HL062243-03 | 2001 | $345,479 | | 5R01HL062243-04 | 2002 | $361,472 | | Total up to 2003 | $1,331,001 |
- OBESITY, INFLAMMATION AND THROMBOSIS: LOOK AHEAD (BALLANTYNE, CHRISTIE - 2007)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2003 | $NA |
Christie Ballantyne Articles (3) [selected PubMed articles for the year 2003 with the links to a full text at PubMed]From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. (2003) >> The Center for Vulnerable Plaque Research, University of Texas-Houston, The Texas Heart Institute, and President Bush Center for Cardiovascular Health, Memorial Hermann Hospital, Houston, USA. 4Lodder, Robert A, 16Fitzgerald, Peter J, 11Jang, Ik-Kyung, 3Rumberger, John, 4Moreno, Pedro, 6Aikawa, Masanori, 2Fayad, Zahi, 12Zipes, Douglas P, 3Rekhter, Mark D, 19Libby, Peter, 10Farb, Andrew, 3Ballantyne, Christie, 16Drexler, Helmut, 8Stone, Peter H, 3Jackson, Chris, 18Greenland, Philip, 8Galis, Zorina S, 7Kaul, Sanjay, 15Becker, Christoph R, 7Casscells, S Ward, 35Colombo, Antonio, 2March, Keith, 16Grundy, Scott M, 19Schwartz, Robert S, 8Yuan, Chun, 7de Korte, Chris L, 17Priori, Silvia G, 3Burke, Allen, 25Koenig, Wolfgang, 6Badimon, Juan Jose, 6Litovsky, Silvio, 18Shah, Prediman K, 31Mehran, Roxana, 8Hansson, Göran K, 3Vogel, Robert, 2Insull, William, 6Muller, James E, 21Willerson, James T, 12Siscovick, David S, 8Naghavi, Morteza, 7Airaksinen, K E Juhani, 9Pasterkamp, Gerard, 37Ridker, Paul M, 3Bahr, Raymond, 9Raggi, Paolo, 8Madjid, Mohammad, 3Zarrabi, Alireza, 6Waxman, Sergio, 14Faxon, David P, 13Assmann, Gerd, 25Boerwinkle, Eric, 43Serruys, Patrick W, 20Virmani, Renu, 8Navab, Mohamad, 3Demirovic, Jasenka, 10Falk, Erling, 37Stefanadis, Christodoulos, 5Chesebro, James H.From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (2003) >> The Center for Vulnerable Plaque Research, University of Texas-Houston, The Texas Heart Institute, and President Bush Center for Cardiovascular Health, Memorial Hermann Hospital, Houston, USA. 4Lodder, Robert A, 16Fitzgerald, Peter J, 11Jang, Ik-Kyung, 3Juhani Airaksinen, K E, 3Rumberger, John, 4Moreno, Pedro, 6Aikawa, Masanori, 2Fayad, Zahi, 12Zipes, Douglas P, 3Rekhter, Mark D, 19Libby, Peter, 10Farb, Andrew, 3Ballantyne, Christie, 16Drexler, Helmut, 8Stone, Peter H, 3Jackson, Chris, 18Greenland, Philip, 8Galis, Zorina S, 7Kaul, Sanjay, 15Becker, Christoph R, 7Casscells, S Ward, 35Colombo, Antonio, 2March, Keith, 16Grundy, Scott M, 19Schwartz, Robert S, 8Yuan, Chun, 7de Korte, Chris L, 17Priori, Silvia G, 3Burke, Allen, 25Koenig, Wolfgang, 6Badimon, Juan Jose, 6Litovsky, Silvio, 18Shah, Prediman K, 31Mehran, Roxana, 8Hansson, Göran K, 3Vogel, Robert, 2Insull, William, 6Muller, James E, 21Willerson, James T, 12Siscovick, David S, 8Naghavi, Morteza, 9Pasterkamp, Gerard, 37Ridker, Paul M, 3Bahr, Raymond, 9Raggi, Paolo, 8Madjid, Mohammad, 3Zarrabi, Alireza, 6Waxman, Sergio, 14Faxon, David P, 13Assmann, Gerd, 25Boerwinkle, Eric, 43Serruys, Patrick W, 20Virmani, Renu, 8Navab, Mohamad, 3Demirovic, Jasenka, 10Falk, Erling, 37Stefanadis, Christodoulos, 5Chesebro, James H.Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting. (2003) >> Baylor College of Medicine and the Methodist DeBakey Heart Center, USA. 6Kansas, Geoffrey S, 10Kleiman, Neal S, 1O'Brian Smith, E, 1Turner, Nancy A, 3Conde, Ian D, 1Wayne Smith, C, 1Snapp, Karen R, 1Frangogiannis, Nikolaos, 1Klem, Jeffrey A, 1Bennet, Nelson, 1Mathew, Shiba, 3Ballantyne, Christie, 1Fernandes, Laura S, 7McIntire, Larry V, 1Maresh, Kelley J.
Science Trivia (2) [Interactive math & science trivia questions]
|
|